GlaxoSmithKline (JOBS) Warns of Anemia Risk with Transplant Drug

Reuters -- GlaxoSmithKline PLC and U.S. regulators said on Thursday they had notified healthcare professionals that a type of anemia has been reported in some patients treated with transplant drug Myfortic.